Vaccine production

The WHO recommends CTAB (Cetrimonium Bromide) in bacterial vaccine manufacturing as a purification agent for the manufacturing of polysaccharide vaccines. It is also used for precipitation of DNA (gene therapy) vaccines.

Novo Nordisk Pharmatech is the only quaternary ammonium compound (Quat) manufacturer offering CTAB in cGMP manufactured pharmaceutical grade, in full compliance with ICH Q7.

This means:

• Full traceability
• High product purity
• Full USP/NF compliance
• Audit access
• Full regulatory documentation package
• Manufactured under fully validated processes

Novo Nordisk Pharmatech A/S has more than 65 years’ experience in manufacturing Quats. We are part of Novo Nordisk, a Danish healthcare company and world leader in diabetes care. We are the leading worldwide supplier of recombinant insulin for cell growth media and pharmaceutical grade quaternary ammonium compounds (Quats) for the pharmaceutical and biopharmaceutical industries.

Contact

Mette Borgaard
Customer Service Assistant

Phone: +45 2429 4134
Email